Close

Industry Reports

Novartis to buy The Medicines Company for $9.7bn

Novartis has signed a definitive agreement to acquire US-based The Medicines Company for a total consideration of $9.7bn, or $85 per share. The deal value is...

Recipharm Offers to Acquire Consort Medical to Become a...

Recipharm AB and Consort Medical plc have reached an agreement on the terms of a recommended cash offer by Recipharm Holdings Limited, a wholly-owned direct...

Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma to...

Aerie Pharmaceuticals , an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma,...

Cytel acquires MTEK Sciences, further expanding its advanced real...

Cytel Inc. the leading provider of innovative analytical software and consulting services to the biopharmaceutical sector, and a portfolio company of New Mountain Capital, announced...

CPhI Annual Report foresees massive shortfalls in advanced therapy...

CPhI Worldwide – the world’s largest pharma event, taking place in Frankfurt, Germany (5-7 November, 2019) – releases the third part of its annual report...

Aptar Acquires Noble International, a Leader in Drug Delivery...

AptarGroup, Inc , a global leader in consumer dispensing, active packaging and drug delivery solutions, announced that it has acquired Noble International, a leader in...

Thermo Fisher Scientific Completes Acquisition of GSK Manufacturing Site...

Thermo Fisher Scientific Inc, the world leader in serving science, has completed its previously announced acquisition of an active pharmaceutical ingredient (API) manufacturing facility from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read